Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDNL.L Share News (DNL)

  • There is currently no data for DNL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXECUTIVE CHANGES: Halma hires non-exec; Diurnal names new chair

Mon, 15th Nov 2021 14:15

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and not separately reported by Alliance News:

----------

Halma PLC - Amersham, England-based safety equipment company - Names Sharmila Nebhrajani as an independent non-executive director, effective from December 1. Nebhrajani will also be a member of Halma's audit, remuneration & nomination committees. She is currently a non-executive director at ITV PLC and Severn Trent PLC, and chair of the National Institute for Health & Care Excellence.

----------

Diurnal Group PLC - Cardiff, Wales-based pharmaceutical company - Reports the appointment of three new members to its board. Anders Harfstrand joins as non-executive chair, while Deborah Jorn and Jean-Michel Cossery join as non-executive directors, respectively, all with immediate effect. Following the appointment of Harfstrand as non-executive chair, Sam Williams, who has held the role of interim chair since March 2020, will resume his role as a non-executive director and board representative of IP Group PLC.

----------

Angle PLC - Guilford, England-based liquid biopsy company - Appoints Todd Druley to the newly created role of chief medical officer, based in the US. The company says Druley brings highly relevant clinical and business expertise to the planning, development and commercialisation of Angle's diagnostics offerings through its clinical laboratories, regulatory filings and pharma services. Druley held the position of chief medical officer at ArcherDX Inc, a genomic analysis company, before it was acquired by Invitae Corp.

----------

Surgical Innovations Group PLC - Leeds-based medical instrument manufacturing company - Promotes Charmaine Day as chief financial officer with immediate effect. She joined Surgical Innovations in 2012 as financial controller, beginning her career in finance for Eville & Jones Ltd and later as management accountant at Ellis Fairbank PLC. In addition, the company says it considers appropriate board structure to fulfill the future strategic and governance needs of the business. The outcome of this review concludes that the optimal structure is a board of five directors comprising three non-executive directors and two executive directors. As a result, two of the current directors, Alistair Taylor and Adam Power, have indicated their intention to step down from the board with effect from the end of 2021.

----------

Induction Healthcare Group PLC - London-based hospital IT systems provider - Appoints Guy Mitchell as chief financial officer, with immediate effect. He has spent the last ten years specialising in high growth, private equity and venture capital backed software/technology companies, typically businesses with software-as-a-service models and with a global reach and customer base.

----------

By Evelina Grecenko; evelinagrecenko@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
11 May 2020 13:07

UK EXECUTIVE CHANGE SUMMARY: Abcam Board Confirms Support For Chair

UK EXECUTIVE CHANGE SUMMARY: Abcam Board Confirms Support For Chair

Read more
15 Apr 2020 14:32

UK TRADING UPDATE SUMMARY: Kromek To Make 2,000 Ventilators For UK

UK TRADING UPDATE SUMMARY: Kromek To Make 2,000 Ventilators For UK

Read more
1 Apr 2020 14:47

Diurnal Gets European Marketing Authorisation For Chronocort

Diurnal Gets European Marketing Authorisation For Chronocort

Read more
6 Mar 2020 17:12

UPDATE: Diurnal Placing Raises GBP11 Million For Drug Development

UPDATE: Diurnal Placing Raises GBP11 Million For Drug Development

Read more
6 Mar 2020 12:40

Diurnal Announces GBP7 Million Placing To Fund Drug Development

Diurnal Announces GBP7 Million Placing To Fund Drug Development

Read more
6 Mar 2020 10:07

Diurnal raises at least ?7m through conditional placing

(Sharecast News) - Speciality pharmaceutical company Diurnal Group announced a conditional placing with institutional investors on Friday, to raise at least ?7m before expenses, at a price of 32p per new share.

Read more
5 Mar 2020 17:21

Diurnal Group Names Director Sam Williams Interim Chair

Diurnal Group Names Director Sam Williams Interim Chair

Read more
13 Feb 2020 13:07

Diurnal Says US FDA Accepts New Drug Application For Alkindi Sprinkle

Diurnal Says US FDA Accepts New Drug Application For Alkindi Sprinkle

Read more
13 Feb 2020 09:47

Diurnal clears FDA hurdle for 'Alkindi Sprinkle'

(Sharecast News) - Speciality pharmaceutical company Diurnal Group announced on Thursday that its new drug application (NDA) for 'Alkindi', or hydrocortisone granules in capsules for opening and to be known in the US as 'Alkindi Sprinkle', has been accepted for review by the US Food and Drug Administration (FDA).

Read more
11 Feb 2020 13:45

Diurnal narrows loss as it progresses drugs to market

(Sharecast News) - Speciality pharmaceutical company Diurnal Group narrowed its first-half loss by 53% to ?4.6m, it announced on Tuesday, which it said reflected improved revenues and a reduction in clinical development expenses for the period.

Read more
11 Feb 2020 09:20

Diurnal Loss Narrows In First Half Amid Improved Sales Of Alkindi

Diurnal Loss Narrows In First Half Amid Improved Sales Of Alkindi

Read more
4 Feb 2020 15:54

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
20 Jan 2020 11:17

Diurnal In Good Health Ahead Of Second Half Amid Alkindi Progress

Diurnal In Good Health Ahead Of Second Half Amid Alkindi Progress

Read more
16 Dec 2019 13:20

Diurnal Submits Market Authorisation Application For Chronocort

Diurnal Submits Market Authorisation Application For Chronocort

Read more
2 Dec 2019 14:40

Diurnal Submits New Drug Application For Aklindi Sprinkle In US

Diurnal Submits New Drug Application For Aklindi Sprinkle In US

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.